Evidence map›Paper›PMID 39563446›Full record

ArticleCell communication and signaling : CCS2024

Arachidonic acid impairs natural killer cell functions by disrupting signaling pathways driven by activating receptors and reactive oxygen species.

Mohamad K Hammoud, Celina Meena, Raimund Dietze, Nathalie Hoffmann, Witold Szymanski, Florian Finkernagel, Andrea Nist, Thorsten Stiewe, Johannes Graumann, Elke Pogge von Strandmann and 1 more

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Metabolomics Analysis of the Mechanism of Yuquan Capsules in the Treatment of T2DM Rats Using UPLC/MS.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mohamad K HammoudDepartment of Translational Oncology, Center for Tumor Biology and Immunology, Philipps University, Marburg, Germany.
Celina MeenaInstitute of Tumor Immunology, Center for Tumor Biology and Immunology, Philipps University, Marburg, Germany.
Raimund DietzeDepartment of Translational Oncology, Center for Tumor Biology and Immunology, Philipps University, Marburg, Germany.
Nathalie HoffmannInstitute of Tumor Immunology, Center for Tumor Biology and Immunology, Philipps University, Marburg, Germany.
Witold SzymanskiInstitute of Translational Proteomics, Biochemical/Pharmacological Centre, Philipps University, Marburg, Germany.
Florian FinkernagelDepartment of Translational Oncology, Center for Tumor Biology and Immunology, Philipps University, Marburg, Germany.
Andrea NistGenomics Core Facility, Philipps University, Marburg, Germany.
Thorsten StieweGenomics Core Facility, Philipps University, Marburg, Germany.
Johannes GraumannInstitute of Translational Proteomics, Biochemical/Pharmacological Centre, Philipps University, Marburg, Germany.
Elke Pogge von StrandmannInstitute of Tumor Immunology, Center for Tumor Biology and Immunology, Philipps University, Marburg, Germany. poggevon@staff.uni-marburg.de.
Rolf MüllerDepartment of Translational Oncology, Center for Tumor Biology and Immunology, Philipps University, Marburg, Germany. rolf.mueller@uni-marburg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh levels of the polyunsaturated fatty acid arachidonic acid (AA) within the ovarian carcinoma (OC) microenvironment correlate with reduced relapse-free survival. Furthermore, OC progression is tied to compromised immunosurveillance, partially attributed to the impairment of natural killer (NK) cells. However, potential connections between AA and NK cell dysfunction in OC have not been studied.

methodsWe employed a combination of phosphoproteomics, transcriptional profiling and biological assays to investigate AA's impact on NK cell functions.

resultsAA (i) disrupts interleukin-2/15-mediated expression of pro-inflammatory genes by inhibiting STAT1-dependent signaling, (ii) hampers signaling by cytotoxicity receptors through disruption of their surface expression, (iii) diminishes phosphorylation of NKG2D-induced protein kinases, including ERK1/2, LYN, MSK1/2 and STAT1, and (iv) alters reactive oxygen species production by transcriptionally upregulating detoxification. These modifications lead to a cessation of NK cell proliferation and a reduction in cytotoxicity.

conclusionOur findings highlight significant AA-induced alterations in the signaling network that regulates NK cell activity. As low expression of several NK cell receptors correlates with shorter OC patient survival, these findings suggest a functional linkage between AA, NK cell dysfunction and OC progression.

Indexed as

Arachidonic AcidKiller Cells, NaturalReactive Oxygen SpeciesSignal TransductionCell Line, TumorCell ProliferationFemaleHumansOvarian NeoplasmsSTAT1 Transcription FactorArachidonic AcidReactive Oxygen SpeciesSTAT1 Transcription FactorArachidonic acidCytotoxicity receptorsInterleukin 2Natural killer (NK) cellsNKG2DOvarian carcinomaPhosphoproteomicsReactive oxygen speciesSTAT1

Identifiers

PMID39563446
PMCPMC11575453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.